NCT02537041

Brief Summary

SITUATION ON RESEARCH Diastolic heart failure (HF) or heart failure with preserved systolic function (SF) is the primary cause of heart failure in the elderly (over 2/3 of heart failure in patients over 60 years). Its main cause is hypertension. The diagnosis of diastolic heart failure is still controversial in clinical practice. It is based on ultrasound and biological criteria (or MRI). Basically, it is concerned patients making acute pulmonary edema with preserved SF and high BNP. It is now recognized that the "primum movens" of this type of HF is increased myocardial stiffness secondary to LVH. Noninvasive assessment of this parameter would allow a more accurate and reliable diagnosis because not dependent on load conditions unlike the ejection fraction (EF) and trans-mitral Doppler. However, the absence of non-invasive tool for the direct evaluation of the diastolic stiffness (so-called passive) prevents to date to use this diagnostic parameter. The investigators propose here to evaluate noninvasively myocardial stiffness in elderly patients with diastolic heart failure using a new imaging tool that uses an innovative ultrasonic technology, the ultrafast echo associated with its elastography function "ShearWave Imaging" (SWI). The investigators work for several years in collaboration with the Langevin Institute on this technology which was recently validated in experimental models. Its principle is based on the creation of a shear wave from a standard ultrasound and calculating the velocity of this wave with the high time resolution of the ultrasound probe, this being correlated with the speed myocardial stiffness. The human study was recently made possible by the development of a phased array probe having the opportunity to work with elastography mode (SWI). PURPOSE OF RESEARCH The goal will be to demonstrate the interest of the non-invasive evaluation by ultrafast echo (SWI) of myocardial stiffness in the diagnosis of diastolic heart failure in the elderly.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 24, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 1, 2015

Completed
Same day until next milestone

Study Start

First participant enrolled

September 1, 2015

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
Last Updated

November 6, 2017

Status Verified

October 1, 2017

Enrollment Period

1.5 years

First QC Date

August 24, 2015

Last Update Submit

October 31, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • myocardial stiffness ( measured by kPa)

    18 months

Study Arms (3)

healthy volunteers

OTHER

to obtain normal values diastolic myocardial stiffness references. The objective will be to confirm the increase with age in myocardial stiffness assessed by elastography in healthy subjects.

Procedure: elastography function ShearWave ImagingProcedure: MRI

diastolic Heart Failure

OTHER

older patients with isolated diastolic HF (EF\> 45%, 60-80 years, n = 20) and infiltrative cardiomyopathy restrictive-type amyloidosis (n = 20) . The objective will be to study the results of elastography on two separate clinical types of IC diastolic well identified.

Procedure: elastography function ShearWave ImagingProcedure: MRI

systolic Heart Failure

OTHER

elderly patients with heart failure with impaired ejection (\<45%) fraction, but no segmental dysfunction. The evaluation of myocardial stiffness by elastography in all these patients will be compared to conventionally ultrasound and biological parameters currently used for diagnosis of elderly's diastolic HF

Procedure: elastography function ShearWave ImagingProcedure: MRI

Interventions

non-invasive assessment of myocardial stiffness by elastography

diastolic Heart Failurehealthy volunteerssystolic Heart Failure
MRIPROCEDURE
diastolic Heart Failurehealthy volunteerssystolic Heart Failure

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Group 1 "healthy volunteers" (n = 40): two age classes determined (\[20-40ans, n = 20\] and \[60-80 years, n = 20\]),
  • Group 2 "diastolic HF" (n = 40): older patients with isolated diastolic HF (EF\> 45%, 60-80 years, n = 20) and infiltrative cardiomyopathy restrictive-type amyloidosis (n = 20)
  • Group 3 "systolic HF" (n = 20): elderly patients with heart failure with impaired ejection (\<45%) fraction, but no segmental dysfunction

You may not qualify if:

  • pregnant woman
  • atrial fibrillation
  • patient with defibrillator, pacemaker
  • contraindication to MRI
  • no consent form
  • echography gel allergy
  • participation to another study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Europeen Georges Pompidou

Paris, 75015, France

Location

Related Publications (1)

  • Villemain O, Correia M, Mousseaux E, Baranger J, Zarka S, Podetti I, Soulat G, Damy T, Hagege A, Tanter M, Pernot M, Messas E. Myocardial Stiffness Evaluation Using Noninvasive Shear Wave Imaging in Healthy and Hypertrophic Cardiomyopathic Adults. JACC Cardiovasc Imaging. 2019 Jul;12(7 Pt 1):1135-1145. doi: 10.1016/j.jcmg.2018.02.002. Epub 2018 Mar 14.

MeSH Terms

Conditions

Heart Failure, Diastolic

Condition Hierarchy (Ancestors)

Heart FailureHeart DiseasesCardiovascular Diseases

Study Officials

  • Olivier VILLEMAIN, MD

    LAngevin Institute

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 24, 2015

First Posted

September 1, 2015

Study Start

September 1, 2015

Primary Completion

March 1, 2017

Study Completion

July 1, 2017

Last Updated

November 6, 2017

Record last verified: 2017-10

Locations